Amylo-IC50Pred is a machine learning–based web server designed to screen compounds against amyloid-β. It identifies whether a compound acts as an inhibitor or a decoy, further classifies inhibitors based on their inhibition potency (good, moderate, or poor), and predicts their IC₅₀ values. Additionally, the platform provides key molecular descriptor values that are most influential in determining the inhibitory activity of the compounds.
PKM2Pred: An AI Tool for Rapid Identification and Potency Estimation of PKM2-Targeting Anticancer Compounds, it introduces a user-friendly AI-based tool that instantly discovers potent PKM2 modulators and predicts their bioactivity, driving faster and smarter anticancer drug discovery.